Bois F, Moreau S, Coudert P, Rubat C, Couquelet J
Groupe de Recherche en Pharmacochimie-Laboratoire de Chimie Thérapeutique, Faculté de Pharmacie, Université d'Auvergne, Clermont-Ferrand, France.
Arzneimittelforschung. 1998 Dec;48(12):1156-62.
The synthesis and spectral data of some new cyclohexane-2-spiro-[2,5-dihydro-3-(N-arylpiperazin-1-yl-carbonyl) -4-methyl- 5-oxo]furanes are reported. These compounds were subjected to pharmacological tests for evaluation of antinociceptive effects and interactions with opioidergic and monoaminergic systems. With respective ED50 values of 116.4 and 87.0 mg/kg i.p., derivatives 2b and 2e were the most active spirobutenolides in the phenylbenzoquinone-induced writhing test (PBQ-test) without neurotoxic effects. They potentiated morphine analgesia and were also active at the dose of 150 mg/kg i.p. in the hot plate test while they exhibited sedative effects from the dose of 100 mg/kg i.p. In addition, 2b and 2e analgesia was antagonized by naloxone, then again potentiated by 5-hydroxytryptophan associated to carbidopa in the PBQ-test, demonstrating involvement of opioidergic and serotonergic pathways in the analgesic properties of both compounds. Furthermore, antinociceptive effects of 2e were attenuated by oral administration of yohimbine suggesting that its analgesic activity was also partly related to a noradrenergic mechanism.
报道了一些新型环己烷-2-螺-[2,5-二氢-3-(N-芳基哌嗪-1-基羰基)-4-甲基-5-氧代]呋喃的合成及光谱数据。对这些化合物进行了药理学测试,以评估其抗伤害感受作用以及与阿片样物质能和单胺能系统的相互作用。在苯醌诱导的扭体试验(PBQ试验)中,衍生物2b和2e的腹腔注射半数有效剂量(ED50)分别为116.4和87.0 mg/kg,是最具活性的螺丁烯内酯,且无神经毒性作用。它们增强了吗啡镇痛作用,在热板试验中腹腔注射150 mg/kg剂量时也具有活性,而腹腔注射100 mg/kg剂量时则表现出镇静作用。此外,在PBQ试验中,2b和2e的镇痛作用被纳洛酮拮抗,然后又被与卡比多巴联合使用的5-羟色氨酸增强,这表明两种化合物的镇痛特性涉及阿片样物质能和5-羟色胺能途径。此外,口服育亨宾可减弱2e的抗伤害感受作用,表明其镇痛活性也部分与去甲肾上腺素能机制有关。